RET and familial medullary thyroid carcinoma: It includes three distinct clinical subtypes, MEN-2a, MEN-2b, and familial medullary thyroid carcinoma (FMTC), associated with a germline missense PV of variable penetrance in the RET proto-oncogene [175,176].